{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:08:54Z","timestamp":1790467734179,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s40264-013-0082-2","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T08:21:22Z","timestamp":1372926082000},"page":"1069-1078","source":"Crossref","is-referenced-by-count":18,"title":["Identifying Associations between Maternal Medication Use and Birth Defects Using a Case-Population Approach: An Exploratory Study on Signal Detection"],"prefix":"10.1007","volume":"36","author":[{"given":"Linda","family":"de Jonge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla A.","family":"Zetstra-van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Jens","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolkje T. W.","family":"de Jong-van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian K.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"82_CR1","volume-title":"Langman\u2019s medical embryology","author":"TW Sadler","year":"2006","unstructured":"Sadler TW. Langman\u2019s medical embryology. 10th ed. Baltimore: Lippincott Williams and Wilkins; 2006.","edition":"10"},{"issue":"2","key":"82_CR2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","volume":"191","author":"SE Andrade","year":"2004","unstructured":"Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398\u2013407.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"82_CR3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/j.1600-0412.1999.780805.x","volume":"78","author":"C Olesen","year":"1999","unstructured":"Olesen C, Sorensen HT, de Jong-van den Berg LTW, et al. Prescribing during pregnancy and lactation with reference to the Swedish classification system: a population-based study among Danish women. Acta Obstet Gynecol Scand. 1999;78(8):686\u201392.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"82_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002280050608","volume":"55","author":"C Olesen","year":"1999","unstructured":"Olesen C, Steffensen FH, Niesen GL, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women: the EUROMAP group. Eur J Clin Pharmacol. 1999;55(2):139\u201344.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"82_CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e31818d6788","volume":"113","author":"CS Buhimschi","year":"2009","unstructured":"Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: part 1. Teratology. Obstet Gynecol. 2009;113(1):166\u201388.","journal-title":"Obstet Gynecol"},{"key":"82_CR6","doi-asserted-by":"crossref","unstructured":"Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: part 2. Drugs with minimal or unknown human teratogenic effect. Obstet Gynecol. 2009;113(2 Pt 1):417\u201332.","DOI":"10.1097\/AOG.0b013e31818d686c"},{"issue":"5","key":"82_CR7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1471-0528.2006.00927.x","volume":"113","author":"MK Bakker","year":"2006","unstructured":"Bakker MK, Jentink J, Froom F, et al. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006;113(5):559\u201368.","journal-title":"BJOG"},{"issue":"2","key":"82_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00002018-200831020-00006","volume":"31","author":"FA Etwel","year":"2008","unstructured":"Etwel FA, Rieder MJ, Bend JR, et al. A surveillance method for the early identification of idiosyncratic adverse drug reactions. Drug Saf. 2008;31(2):169\u201380.","journal-title":"Drug Saf"},{"issue":"22","key":"82_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archinte.159.4.369","volume":"159","author":"MM Klauw Van der","year":"1999","unstructured":"Van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159(22):369\u201374.","journal-title":"Arch Intern Med"},{"issue":"1","key":"82_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00002018-200225010-00002","volume":"25","author":"D Capell\u00e0","year":"2002","unstructured":"Capell\u00e0 D, Pedr\u00f3s C, Vidal X, et al. Case-population studies in pharmacoepidemiology. Drug Saf. 2002;25(1):7\u201319.","journal-title":"Drug Saf"},{"issue":"10","key":"82_CR11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/11592140-000000000-00000","volume":"34","author":"H Th\u00e9ophile","year":"2011","unstructured":"Th\u00e9ophile H, Laporte JR, Moore N, et al. The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf. 2011;34(10):861\u20138.","journal-title":"Drug Saf"},{"key":"82_CR12","first-page":"51","volume":"91","author":"R Greenlees","year":"2011","unstructured":"Greenlees R, Neville A, Addor MC, et al. Paper 6: EUROCAT Member Registries: organization and activities. Birth defects research (part A): clinical and molecular. Teratology. 2011;91:51\u2013100.","journal-title":"Teratology"},{"key":"82_CR13","unstructured":"World Health Organization. International statistical classification of diseases and related health problems. 10th revision (ICD-10). Geneva: WHO, 1992."},{"key":"82_CR14","unstructured":"World Health Organization. Collaborating Centre for Drugs Statistics Methodology. ATC\/DDD Index. 2012. http:\/\/www.whocc.no\/atc_ddd_index\/ . Accessed 30 Aug 2012."},{"issue":"9","key":"82_CR15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/bdra.20388","volume":"79","author":"MK Bakker","year":"2007","unstructured":"Bakker MK, de Walle HEK, Dequito A, et al. Selection of controls in case-control studies on maternal medication use and risk of birth defects. Birth Defects Res A Clin Mol Teratol. 2007;79(9):652\u20136.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"82_CR16","unstructured":"Eurocat guidelines. http:\/\/www.eurocat-network.eu\/ \u00e0 about us \u00e0 data collection. Accessed 12 March 2013."},{"issue":"7","key":"82_CR17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2002.12.001","volume":"57","author":"E Schirm","year":"2004","unstructured":"Schirm E, Tobi H, de Jong-van den Berg LTW. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol. 2004;57(7):737\u201341.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"82_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1517\/14740338.7.2.195","volume":"7","author":"MJ Eadie","year":"2008","unstructured":"Eadie MJ. Antiepileptic drugs as human teratogens. Expert Opin Drug Saf. 2008;7(2):195\u2013210.","journal-title":"Expert Opin Drug Saf"},{"issue":"23","key":"82_CR19","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","volume":"362","author":"J Jentink","year":"2010","unstructured":"Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185\u201393.","journal-title":"N Engl J Med"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"c6581","DOI":"10.1136\/bmj.c6581","volume":"341","author":"J Jentink","year":"2010","unstructured":"Jentink J, Dolk H, Loane MA, et al. Intrauterine carbamazepine exposure and specific congenital malformations. BMJ. 2010;341:c6581.","journal-title":"BMJ"},{"issue":"2","key":"82_CR21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","volume":"64","author":"DF Wyszynski","year":"2005","unstructured":"Wyszynski DF, Nambisan M, Surve T, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology. 2005;64(2):961\u20135.","journal-title":"Neurology"},{"issue":"11","key":"82_CR22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","volume":"21","author":"MM Werler","year":"2011","unstructured":"Werler MM, Ahrens KA, Bosco JL, et al. Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol. 2011;21(11):842\u201350.","journal-title":"Ann Epidemiol"},{"issue":"10","key":"82_CR23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.wnl.0000316194.98475.d8","volume":"71","author":"H Dolk","year":"2008","unstructured":"Dolk H, Jenktink J, Loane MA, et al. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology. 2008;71(10):714\u201322.","journal-title":"Neurology"},{"issue":"9","key":"82_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.seizure.2010.07.019","volume":"19","author":"FJE Vajda","year":"2010","unstructured":"Vajda FJE, Graham JE, Hitchcock AA, et al. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure. 2010;19(9):558\u201361.","journal-title":"Seizure"},{"key":"82_CR25","unstructured":"http:\/\/www.tga.gov.au\/hp\/medicines-pregnancy.htm . Accessed 9 Feb 2012."},{"key":"82_CR26","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease association or causation. Proc R Soc Med. 1965;58:295\u2013300.","journal-title":"Proc R Soc Med"},{"issue":"6","key":"82_CR27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00002018-199716060-00002","volume":"16","author":"RH Meyboom","year":"1997","unstructured":"Meyboom RH, Egberts AC, Edwards IR, et al. Principles of signal detection in pharmacovigilance. Drug Saf. 1997;16(6):355\u201365.","journal-title":"Drug Saf"},{"issue":"6","key":"82_CR28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200225060-00011","volume":"25","author":"RH Meyboom","year":"2002","unstructured":"Meyboom RH, Lindquist M, Egberts AC, et al. Signal selection and follow-up in pharmacovigilance. Drug Saf. 2002;25(6):459\u201365.","journal-title":"Drug Saf"},{"issue":"2","key":"82_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","volume":"98","author":"C Kozma","year":"2001","unstructured":"Kozma C. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet. 2001;98(2):168\u201375.","journal-title":"Am J Med Genet"},{"issue":"8","key":"82_CR30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/pds.1964","volume":"19","author":"MK Bakker","year":"2010","unstructured":"Bakker MK, de Walle HEK, Wilffert B, et al. Fluoxetine and infantile hypertrophic pylorus stenosis, a signal from a birth defects case-control monitoring system. Pharmacoepidemiol Drug Saf. 2010;19(8):808\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"82_CR31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","volume":"91","author":"L Colvin","year":"2011","unstructured":"Colvin L, Slack-Smith L, Stanley FJ, et al. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol. 2011;91(3):142\u201352.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"82_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","volume":"118","author":"H Malm","year":"2011","unstructured":"Malm H, Artama M, Gissler M, et al. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol. 2011;118(1):111\u201320.","journal-title":"Obstet Gynecol"},{"key":"82_CR33","doi-asserted-by":"crossref","first-page":"b3569","DOI":"10.1136\/bmj.b3569","volume":"339","author":"LH Pedersen","year":"2009","unstructured":"Pedersen LH, Henriksen TB, Vestergaard M, et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ. 2009;339:b3569.","journal-title":"BMJ"},{"issue":"5","key":"82_CR34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/BPO.0b013e3181aa586b","volume":"29","author":"DA Stevenson","year":"2009","unstructured":"Stevenson DA, Mineau G, Kerber RA, et al. Familial predisposition to developmental dysplasia of the hip. J Pediatr Orthop. 2009;29(5):463\u20136.","journal-title":"J Pediatr Orthop"},{"issue":"26","key":"82_CR35","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","volume":"356","author":"C Louik","year":"2007","unstructured":"Louik C, Lin AE, Werler MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356(26):2675\u201383.","journal-title":"N Engl J Med"},{"issue":"10","key":"82_CR36","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","volume":"40","author":"M Reis","year":"2010","unstructured":"Reis M, K\u00e4ll\u00e9n B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40(10):1723\u201333.","journal-title":"Psychol Med"},{"issue":"2","key":"82_CR37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/bdra.20641","volume":"88","author":"MK Bakker","year":"2010","unstructured":"Bakker MK, Kerstjens-Frederikse WS, Buys CH, et al. First trimester use of paroxetine and congenital heart defects, a population-based case-control study. Birth Defects Res A Clin Mol Teratol. 2010;88(2):94\u2013100.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"82_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bdra.20655","volume":"88","author":"AR Scialli","year":"2010","unstructured":"Scialli AR. Paroxetine exposure during pregnancy and cardiac malformations. Birth Defects Res A Clin Mol Teratol. 2010;88:175\u20137.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"1","key":"82_CR39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.HYP.22.1.127","volume":"22","author":"MD Lindheimer","year":"1993","unstructured":"Lindheimer MD. Hypertension in pregnancy. Hypertension. 1993;22(1):127\u201337.","journal-title":"Hypertension"},{"issue":"6","key":"82_CR40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-009-0620-0","volume":"65","author":"R Lennestal","year":"2009","unstructured":"Lennestal R, Otterblad Olausson PO, K\u00e4ll\u00e9n B, et al. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of heart defects in the infants. Eur J Clin Pharmacol. 2009;65(6):615\u201325.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"82_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.109.129098","volume":"54","author":"AR Caton","year":"2009","unstructured":"Caton AR, Bell EM, Druschel CM, et al. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension. 2009;54(1):63\u201370.","journal-title":"Hypertension"},{"key":"82_CR42","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","volume":"343","author":"DK Li","year":"2011","unstructured":"Li DK, Yang C, Andrade S, et al. Maternal exposure to ACE-inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ. 2011;343:d5931.","journal-title":"BMJ"},{"key":"82_CR43","doi-asserted-by":"crossref","first-page":"d6667","DOI":"10.1136\/bmj.d6667","volume":"343","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA. Fetal risk from ACE inhibitors in the first trimester. BMJ. 2011;343:d6667.","journal-title":"BMJ"},{"key":"82_CR44","doi-asserted-by":"crossref","unstructured":"De Jong-van den Berg LTW, Waardenburg CM, Haaijer-Ruskamp FM, et al. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol. 1993;45(1):9\u201314.","DOI":"10.1007\/BF00315343"},{"issue":"5","key":"82_CR45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001648-200109000-00006","volume":"12","author":"C Olesen","year":"2001","unstructured":"Olesen C, S\u00f8ndergaard C, Thrane N, et al. Do pregnant women report use of dispensed medication. Epidemiology. 2001;12(5):497\u2013501.","journal-title":"Epidemiology"},{"key":"82_CR46","unstructured":"EUROCAT NNL. http:\/\/www.rug.nl\/umcg\/faculteit\/disciplinegroepen\/medischegenetica\/eurocat\/Algemenecijferstabel123en4.pdf (in Dutch). Accessed 30 Aug 2012."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0082-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0082-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T21:18:23Z","timestamp":1715635103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0082-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0082-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}